Please login to the form below

Not currently logged in
Email:
Password:

safety

This page shows the latest safety news and features for those working in and with pharma, biotech and healthcare.

Sanofi confirms suspected safety issue with dengue vaccine

Sanofi confirms suspected safety issue with dengue vaccine

Sanofi confirms suspected safety issue with dengue vaccine. As rival Takeda conduct phase II testing for its own dengue vaccine candidate. ... Prospects for Sanofi’s dengue fever vaccine Dengvaxia look increasingly dim after it confirmed a long-debated

Latest news

More from news
Approximately 98 fully matching, plus 1,038 partially matching documents found.

Latest Intelligence

  • Brexit Means Brexit Brexit Means Brexit

    As the ABPI says: “It is now critical that both sides prioritise patient safety in phase two of the negotiations.”. ... But it should also begin, privately at least, to stress the potential consumer impacts an alternative position might bring; the

  • A critical juncture for clinical data management A critical juncture for clinical data management

    The top five most commonly used applications include electronic data capture (EDC) with 100% usage, randomisation and trial-supply management applications with 77% usage, both safety/pharmacovigilance and electronic master file

  • The Patient Safety Challenge The Patient Safety Challenge

    The Patient Safety Challenge. Understanding the causes of medication  errors and how to reduce them. ... We were particularly interested in their views of the safety culture of their organisation.

  • A new era of smart pharma A new era of smart pharma

    Blending Reportum with AI and Robotic tools affords pharma companies the opportunity to transform their end-to-end drug safety processes today. ... While there is no doubt that AI can analyse colossal amounts of data faster than humans to reveal patterns

  • Health on instalment Health on instalment

    Before being pulled from the European market for safety concerns and lack of uptake, pancreatic drug Glybera cost $1m a dose.

More from intelligence
Approximately 2 fully matching, plus 108 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 48 partially matching documents found.

Latest from PMHub

  • When is sun safety doing more harm than good?

    When is sun safety doing more harm than good? Say Communications analyses the impact of sun safety campaigns in the news and on consumers.

  • Integration of HEOR into Global Publication Plans

    Integration of HEOR into Global Publication Plans. Downloads. . Integration of HEOR into Global Publication Plans. PDF File: 377.4 KB. 1-267-332-0051 Ext 100. Address:. Cactus Communications Inc. 2 Neshaminy Interplex. Suite 100 Trevose.

  • Spotlight on Events

    and display management of posters and abstracts ·. Design of congress floor plans to meet health and safety requirements at venues ·. Organisation of internal client meetings ·. Marking and display management of posters

  • Magic Numbers

    What ‘ magic’ is this? Well, the sort that can instantly gratify our deep-rooted desire for safety and security: the thought of n=100 makes us feel nice and comfortable, and

  • New Gower Title

    web sites; targeted mass digital campaigns), Improving Self-care (e.g. self-management education; self-monitoring; self-treatment), Improving Patient Safety (e.g.

More from PMHub
Approximately 3 fully matching, plus 70 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics